Equity Capital Markets

Company · CIK 1835022

Coya Therapeutics, Inc.

CIK1835022 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressTX
ListedCOYA (Nasdaq)
First annual or quarterly report2023-03-29

Offerings

6 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-289511
ShelfEffective
2025-08-122026-05-125
333-294315
ShelfEffective
2026-03-162026-03-202
333-283366
ShelfEffective
2024-11-202024-11-292
333-280235
ShelfEffective
2024-06-142024-06-212
333-276374
ShelfEffective
2024-01-042024-01-122
333-268482
IPOFinal prospectus
2022-11-182023-05-127

Filings

21
FiledFilingRegistrationAccession
2026-05-12424B5Shelf takedown 333-2895110001193125-26-218278
2026-03-20EFFECTDeclared effective 333-2943159999999995-26-000895
2026-03-16S-3Shelf registered 333-2943150001193125-26-107413
2025-10-27424B5Shelf takedown 333-2895110001193125-25-250699
2025-10-23424B5Shelf takedown 333-2895110001193125-25-248847
2025-08-19EFFECTDeclared effective 333-2895119999999995-25-002680
2025-08-12S-3Shelf registered 333-2895110001193125-25-178531
2024-11-29EFFECTDeclared effective 333-2833669999999995-24-003622
2024-11-20S-3Shelf registered 333-2833660001193125-24-262623
2024-06-21EFFECTDeclared effective 333-2802359999999995-24-001918
2024-06-14S-3Shelf registered 333-2802350001193125-24-161701
2024-01-12EFFECTDeclared effective 333-2763749999999995-24-000119
2024-01-04S-3Shelf registered 333-2763740001193125-24-002488
2023-05-12424B4Final prospectus 333-2684820001193125-23-143489
2023-05-10EFFECTDeclared effective 333-2684829999999995-23-001362
2022-12-30424B4Final prospectus 333-2684820001564590-22-040078
2022-12-28EFFECTDeclared effective 333-2684829999999995-22-003654
2022-12-13S-1/AAmendment 333-2684820001564590-22-039242
2022-12-05S-1/AAmendment 333-2684820001564590-22-038993
2022-11-18S-1Registration filed 333-2684820001564590-22-038040
2022-08-19DRSDraft made public 377-063240001564590-22-029826

All filings of this company · CSV